DH - CIK 0001861795
The table below shows Definitive Healthcare Corp.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $11.56M | $26.07M | $16.59M | $14.96M | $13.63M | $13.53M |
| Capital expenditure | $3.20M | $7.71M | $266.00K | $1.34M | $794.00K | - |
| Investing cash flow | -$6.22M | $83.55M | -$24.03M | -$33.47M | -$166.85M | -$3.84M |
| Dividends paid | - | - | - | - | - |
Definitive Healthcare Corp. reported operating cash flow of $53.78M for fiscal year 2025. That is down 7.6% from $58.20M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from $23.22M (FY 2020) to $53.78M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $21.16M | $0.00 | - | - | - |
| Financing cash flow | -$10.88M | -$109.71M | -$17.19M | -$3.52M | -$4.38M | -$1.30M |